Fat, protein, and fiber all reduce oral semaglutide bioavailability, so waiting 30 minutes after dosing before eating is essential
Like all organs in your body, your brain changes over time and its best to track these changes regularly
(RFK Jr.) discussed the FDAs current restrictions on peptides, stating his intention was to make peptides more accessible
Ideal candidates typically include patients with: Type 2 diabetes and NAFLD/MASLD : This represents the most straightforward indication, as GLP-1 agonists are FDA-approved for diabetes management
The most frequently reported risks include injection-site pain, redness, or swelling
Regular physical activity also plays a critical role in sustaining weight management